Trident Lifeline Limited (BSE: 543616)
Health Care · Pharmaceuticals · IN
Rs370.00
-1.69% today · +26.7% 1Y
Trident Lifeline Limited (BSE: 543616) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $45.62M.
Over the last twelve months the share price has gained 26.7%, trading between 229.95 and 421.00.
Tweenvest scores Trident Lifeline Limited across four factors: quality 69/100, value 70/100. Its strongest factor is value.
543616 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.62M
- Revenue (TTM)
- $14.72M
- P/E
- 20.67
- EPS
- 17.90
- Dividend yield
- —
- Beta (5Y)
- -0.32
- 52-week high
- Rs421.00
- 52-week low
- Rs229.95
- Avg volume (3M)
- —
- Shares outstanding
- 11.93M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Albert David LimitedBSE: 524075 | $46.62M | Rs790.65 | -7.10% |
| ADBiotech Co., Ltd.KOSDAQ: A179530 | $45.91M | ₩2,290.00 | +11.44% |
| BioStem Technologies, Inc.NasdaqCM: BSEM | $45.90M | $2.47 | -9.52% |
| Pharmedic Pharmaceutical Medicinal Joint Stock CompanyHNX: PMC | $45.63M | ₫127,000.00 | +1.68% |
| Vext Science, Inc.CNSX: VEXT | $45.14M | CA$0.26 | +15.56% |
| Yuyu Pharma, Inc.KOSE: A000220 | $44.98M | ₩3,840.00 | +1.59% |
| Oncoinvent ASAOB: ONCIN | $44.84M | Nkr69.40 | -0.86% |
| Advagene Biopharma Co., Ltd.TPEX: 6709 | $44.48M | NT$23.95 | -0.21% |
Figures last refreshed Oct 11, 2026.